Causal effects of gut microbiome on aortic dissection: A mendelian randomization study

Yu Tian1, Furong Hao2, Guangyang Xu3

  • 1Vascular Surgery Department, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, China; School of Clinical Medicine, Tsinghua University, Beijing, China.

Clinics (Sao Paulo, Brazil)
|November 20, 2025
PubMed
Abstract

Insights

This study explored the gut microbiome

Area of Science:

  • Microbiome Research
  • Vascular Disease Genetics
  • Human Health and Disease

Background:

  • Aortic Dissection (AD) is a life-threatening vascular condition with a high mortality rate.
  • The gut microbiome's role in the chronic development of AD is increasingly recognized.
  • Understanding the gut microbiome's influence is crucial for developing novel therapeutic strategies for AD.

Purpose of the Study:

  • To investigate the potential causal relationship between specific gut microbiota and Aortic Dissection (AD).
  • To identify gut microbial taxa that may confer a protective effect or increase the risk of AD.
  • To leverage Mendelian Randomization (MR) for robust causal inference in AD etiology.

Main Methods:

  • A two-sample Mendelian Randomization (MR) approach was utilized.
  • Genome-Wide Association Study (GWAS) data from a Finnish population was analyzed.
  • Instrumental variables were derived from Single Nucleotide Polymorphisms (SNPs) associated with 473 gut microbial taxa.

Main Results:

  • Several gut bacteria, including Actinomycetales and Prevotella sp002933775, showed a potential protective association with AD.
  • Other taxa, such as Pseudomonas aeruginosa and Bacteroides eggerthii, were identified as potential risk factors for AD.
  • Sensitivity analyses confirmed the reliability and robustness of the identified associations.

Conclusions:

  • This research highlights specific gut microbial taxa as potential modulators of Aortic Dissection (AD) risk.
  • The findings suggest novel avenues for understanding AD pathogenesis and potential microbiome-targeted interventions.
  • Further validation in diverse populations is recommended to confirm these gut microbiome-AD associations.